ASX:PIQ

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Proteomics International Laboratories

Market Cap

AU$125.2m

Last Updated

2021/07/26 17:26 UTC

Data Sources

Company Financials

Executive Summary

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. More Details

Rewards

Loading...

Risk Analysis

Loading...

Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has Proteomics International Laboratories's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

17.2%

PIQ

-1.4%

AU Life Sciences

2.0%

AU Market


1 Year Return

112.5%

PIQ

2.6%

AU Life Sciences

26.0%

AU Market


Shareholder returns

PIQIndustryMarket
7 Day17.2%-1.4%2.0%
30 Day28.6%-1.7%1.4%
90 Day-5.2%-27.9%4.3%
1 Year112.5%112.5%2.8%2.6%30.6%26.0%
3 Year303.4%303.4%63.7%56.5%33.4%17.2%
5 Year395.8%395.8%-2.9%-13.7%65.0%32.8%

Long-Term Price Volatility Vs. Market

How volatile is Proteomics International Laboratories's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Proteomics International Laboratories undervalued compared to its fair value and its price relative to the market?

15.06x

Price to Book (PB) ratio


Share Price vs. Fair Value


Price To Earnings Ratio


Price to Earnings Growth Ratio


Price to Book Ratio


Future Growth

How is Proteomics International Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.3%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts


Earnings per Share Growth Forecasts


Future Return on Equity


Past Performance

How has Proteomics International Laboratories performed over the past 5 years?

-9.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis


Return on Equity


Financial Health

How is Proteomics International Laboratories's financial position?


Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet


Dividend

What is Proteomics International Laboratories's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market


Stability and Growth of Payments


Current Payout to Shareholders


Future Payout to Shareholders


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.1yrs

Average management tenure


CEO

Richard Lipscombe

7.08yrs

Tenure

AU$299,231

Compensation

Dr. Richard John Lipscombe, Ph.D (London), MA (Oxford), co-founded Proteomics International Laboratories Limited in 2001 and serves as its Managing Director and Director since June 09, 2014. Mr. Lipscombe ...


CEO Compensation Analysis


Leadership Team


Board Members


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume


Ownership Breakdown


Top Shareholders

Company Information

Proteomics International Laboratories Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Proteomics International Laboratories Limited
  • Ticker: PIQ
  • Exchange: ASX
  • Founded: 2001
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$125.195m
  • Shares outstanding: 105.21m
  • Website: https://www.proteomics.com.au

Location

  • Proteomics International Laboratories Limited
  • QEII Medical Centre
  • QQ Block
  • Perth
  • Western Australia
  • 6009
  • Australia

Listings


Biography

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and dev...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/26 17:26
End of Day Share Price2021/07/26 00:00
Earnings2020/12/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.